Kuratsune, Hirohiko, Yamaguti, Kouzi, Lindh, Gudrun et al. · NeuroImage · 2002 · DOI
This study looked at how the brain uses a molecule called acetylcarnitine, which helps cells produce energy. Researchers found that people with ME/CFS have lower levels of acetylcarnitine in their blood, and their brains take up less of this molecule than healthy people do. The reduced uptake happened in several brain areas involved in thinking, emotion, and movement coordination, suggesting this may be connected to why people with ME/CFS experience severe fatigue.
This mechanistic study provides direct neuroimaging evidence linking a measurable biochemical abnormality (low serum acetylcarnitine and reduced brain uptake) to fatigue in ME/CFS. Understanding how the brain's energy metabolism and neurotransmitter production are impaired could eventually lead to targeted therapeutic interventions and help validate ME/CFS as a biological disorder rather than a psychiatric condition.
This study does not establish causation—it shows correlation between reduced acetylcarnitine uptake and fatigue severity but does not prove this is the sole or primary cause of ME/CFS fatigue. The small sample size (8 per group) limits generalizability. The cross-sectional design cannot determine whether the uptake abnormality precedes fatigue onset or results from it.
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
Spotted an error in this entry? Report it →